Endoluminal treatment of peripheral chronic total occlusions using the Crosser® recanalization catheter

Cezar S Staniloae1, Kanika P Mody, Sidharth S Yadav

  • 1NYU Langone Medical Center, Cardiac and Vascular Institute, 550 First Avenue, New York, NY 10016 USA. cezar.staniloae@nyumc.org.

Insights

The Crosser device safely and effectively recanalizes lower extremity chronic total occlusions (CTOs), achieving high success rates, particularly in aorto-iliac and tibial arteries. This technology improves patient outcomes by facilitating guidewire access for revascularization.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Endovascular Therapy

Background:

  • Lower extremity chronic total occlusions (CTOs) present significant revascularization challenges.
  • The Crosser recanalization catheter aims to improve rapid and safe intraluminal guidewire access.

Purpose of the Study:

  • To evaluate the Crosser device as a primary therapy for peripheral CTOs.
  • To assess the technical success and safety of the Crosser device in facilitating distal vessel entry.

Main Methods:

  • A retrospective study of 56 patients with 73 lower extremity CTOs treated with the Crosser device.
  • Primary technical success defined as guidewire delivery solely by Crosser; secondary success included re-entry device use.
  • Safety endpoints included dissections, thromboembolism, and perforations.

Main Results:

  • Overall primary and secondary technical success rates were 76.7% and 87.7%, respectively.
  • Highest success rates observed in aorto-iliac (90.0%) and tibial (95.2%) CTOs.
  • No Crosser-related perforations occurred; lesion length >100mm and calcification predicted failure.

Conclusions:

  • The Crosser device is safe and effective for facilitating guidewire entry in lower extremity CTOs.
  • Efficacy is particularly notable in aorto-iliac and tibial occlusions.
  • Success rates for femoral and popliteal CTOs are comparable to existing techniques.
Abstract